# A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects

> **NCT04577885** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SHR2554 and Rifampin

## Key facts

- **NCT ID:** NCT04577885
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-28
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-09-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04577885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04577885, "A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04577885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*